EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

SESN1 is a FOXO3 effector that counteracts human skeletal muscle ageing

Ying Jing, Yuesheng Zuo, Liang Sun, Zheng-Rong Yu, Shuai Ma, Huifang Hu, Qian Zhao, Daoyuan Huang, Weiqi Zhang iD, Juan Carlos Izpisua Belmonte, Yang Yu, Jing Qu iD and 2 more

Cell Proliferation · 2023-05 · 56 (5)

DOI: 10.1111/cpr.13455 ↗

At a glance

Journal article in Cell Proliferation, published online on 2023-05-17. Written by Ying Jing and 13 co-authors. Institution: State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China. Major MEDLINE topics: Muscle, Skeletal, Sarcopenia, Sestrins. Cited 24 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Key Research and Development Program of China, Strategic Priority Research Program of the Chinese Academy of Sciences, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Sarcopenia, a skeletal muscle disorder in which loss of muscle mass and function progresses with age, is associated with increased overall frailty, risk of falling and mortality in the elders. Here, we reveal that SESN1 safeguards skeletal muscle from ageing downstream of the longevity gene FOXO3 , which we recently reported is a geroprotector in primate skeletal muscle. Knockdown of SESN1 mimicked the human myotube ageing phenotypes observed in the FOXO3‐deficient human myotubes, whereas genetic activation of SESN1 alleviated human myotube senescence. Of note, SESN1 was identified as a protective secretory factor against muscle atrophy. Administration of recombinant SESN1 protein attenuated senescence of human myotubes in vitro and facilitated muscle regeneration in vivo. Altogether, we unveil a key role of SESN1 downstream of FOXO3 in protecting skeletal muscle from ageing, providing diagnostic biomarkers and intervention strategies for counteracting skeletal muscle ageing and related diseases.

Subjects

MeSH terms (MEDLINE)

Muscle, SkeletalSarcopeniaSestrinsAgedAnimalsHumansAgingForkhead Box Protein O3Muscle Fibers, SkeletalMuscular AtrophyTranscription Factors

Substances

Forkhead Box Protein O3FOXO3 protein, humanSESN1 protein, humanSestrinsTranscription Factors

Authors and institutions

  • State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
  • University of Chinese Academy of Sciences, Beijing, China.
  • Advanced Innovation Center for Human Brain Protection, National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital Capital Medical University, Beijing, China.
  • Aging Translational Medicine Center, International Center for Aging and Cancer, Beijing Municipal Geriatric Medical Research Center, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
  • China National Center for Bioinformation, Beijing, China.

ORCID profiles: Weiqi Zhang, Jing Qu, Guang-Hui Liu, Si Wang

Funding

  • National Key Research and Development Program of China
  • Strategic Priority Research Program of the Chinese Academy of Sciences
  • National Natural Science Foundation of China
  • Program of the Beijing Natural Science Foundation
  • K. C. Wong Education Foundation
  • Beijing Medical Research
  • the Pilot Project for Public Welfare Development and Reform of Beijing-affiliated Medical Research Institutes
  • Young Elite Scientists Sponsorship Program by CAST

Cite

APA

Jing, Y., Zuo, Y., Sun, L., Yu, Z. R., Ma, S., Hu, H., Zhao, Q., Huang, D., Zhang, W., Belmonte, J. C. I., Yu, Y., Qu, J., Liu, G. H., & Wang, S. (2023). SESN1 is a FOXO3 effector that counteracts human skeletal muscle ageing. Cell Proliferation, 56(5). https://doi.org/10.1111/cpr.13455

Vancouver

Jing Y, Zuo Y, Sun L, Yu ZR, Ma S, Hu H, et al. SESN1 is a FOXO3 effector that counteracts human skeletal muscle ageing. Cell Proliferation. 2023;56(5). doi:10.1111/cpr.13455

BibTeX
@article{Jing2023,
  author = {Jing, Ying and Zuo, Yuesheng and Sun, Liang and Yu, Zheng-Rong and Ma, Shuai and Hu, Huifang and Zhao, Qian and Huang, Daoyuan and Zhang, Weiqi and Belmonte, Juan Carlos Izpisua and Yu, Yang and Qu, Jing and Liu, Guang-Hui and Wang, Si},
  title = {SESN1 is a FOXO3 effector that counteracts human skeletal muscle ageing},
  journal = {Cell Proliferation},
  year = {2023},
  volume = {56},
  number = {5},
  doi = {10.1111/cpr.13455}
}
Start for free →